Medtronic plc (NYSE: MDT) is 4.10% higher on its value in year-to-date trading and has touched a low of $75.76 and a high of $114.31 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will happen to its price in the coming time. The MDT stock was last observed hovering at around $79.52 in the last trading session, with the day’s gains setting it 1.39%.
Currently trading at $80.91, the stock is 2.82% and 2.11% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 6.81 million and changing 1.75% at the moment leaves the stock -10.02% off its SMA200. MDT registered -24.92% loss for a year compared to 6-month loss of -10.36%.
The stock witnessed a 4.91% gain in the last 1 month and extending the period to 3 months gives it a -3.29%, and is 1.33% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 2.26% over the week and 2.22% over the month.
Medtronic plc (MDT) has around 95000 employees, a market worth around $105.78B and $30.81B in sales. Current P/E ratio is 25.13 and Fwd P/E is 14.89. Profit margin for the company is 14.00%. Distance from 52-week low is 6.79% and -29.22% from its 52-week high. The company has generated returns on investments over the last 12 months (6.90%).
Medtronic plc is expected to release its quarterly report on 02/21/2023.The EPS is expected to grow by 44.20% this year.
Medtronic plc (MDT) Top Institutional Holders
The shares outstanding are 1.33B, and float is at 1.33B with Short Float at 0.89%.
Medtronic plc (MDT) Insider Activity
A total of 27 insider transactions have happened at Medtronic plc (MDT) in the last six months, with sales accounting for 14 and purchases happening 13 times. The most recent transaction is an insider sale by Salmon Sean,the company’sEVP & President Cardiovascular. SEC filings show that Salmon Sean sold 16,631 shares of the company’s common stock on Dec 13 at a price of $80.50 per share for a total of $1.34 million. Following the sale, the insider now owns 36088.0 shares.
Medtronic plc disclosed in a document filed with the SEC on Oct 14 that TEN HOEDT ROB (EVP and Pres. Global Regions) sold a total of 2,404 shares of the company’s common stock. The trade occurred on Oct 14 and was made at $81.54 per share for $0.2 million. Following the transaction, the insider now directly holds 43483.0 shares of the MDT stock.
Still, SEC filings show that on Mar 18, PARKHILL KAREN L (EVP & Chief Financial Officer) disposed off 682 shares at an average price of $110.00 for $75020.0. The insider now directly holds 34,946 shares of Medtronic plc (MDT).
Medtronic plc (MDT): Who are the competitors?
The company’s main competitors (and peers) include Johnson & Johnson (JNJ) that is trading 1.30% up over the past 12 months and Danaher Corporation (DHR) that is -4.40% lower over the same period. Abbott Laboratories (ABT) is -10.50% down on the 1-year trading charts.